Vertex Pharmaceuticals
VRTX
#188
Rank
ยฃ85.08 B
Marketcap
ยฃ331.85
Share price
-0.90%
Change (1 day)
-1.54%
Change (1 year)

Market capitalization of Vertex Pharmaceuticals (VRTX)

Market cap: ยฃ85.08 Billion

As of January 2026 Vertex Pharmaceuticals has a market cap of ยฃ85.08 Billion. This makes Vertex Pharmaceuticals the world's 188th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Vertex Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ85.08 B-3.45%
2025ยฃ88.12 B5.06%
2024ยฃ83.88 B1.93%
2023ยฃ82.29 B34.32%
2022ยฃ61.27 B47.99%
2021ยฃ41.40 B-8.17%
2020ยฃ45.08 B4.26%
2019ยฃ43.24 B29.82%
2018ยฃ33.31 B18.79%
2017ยฃ28.04 B89.37%
2016ยฃ14.80 B-29.19%
2015ยฃ20.91 B13.37%
2014ยฃ18.44 B75.18%
2013ยฃ10.53 B86.95%
2012ยฃ5.63 B26.4%
2011ยฃ4.45 B-3.51%
2010ยฃ4.61 B-12.78%
2009ยฃ5.29 B80.48%
2008ยฃ2.93 B88.81%
2007ยฃ1.55 B-35.51%
2006ยฃ2.40 B38.84%
2005ยฃ1.73 B290.26%
2004ยฃ0.44 B-1.5%
2003ยฃ0.45 B-40.19%
2002ยฃ0.75 B-40.7%
2001ยฃ1.27 B-55.43%
2000ยฃ2.85 B413.3%
1999ยฃ0.55 B22.62%
1998ยฃ0.45 B-10.43%
1997ยฃ0.50 B2.15%
1996ยฃ0.49 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Vertex Pharmaceuticals was reported to be:

ยฃ84.95 Billion
by Nasdaq info icon info icon
ยฃ85.85 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
ยฃ113.96 B 33.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ290.14 B 241.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ203.19 B 138.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ85.22 B 0.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ390.52 B 358.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
ยฃ0.29 B-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA